Weight loss injection study for adults with obesity
Part of Hormones & metabolism clinical trials.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is between 28 and 40.
- Your weight has been stable for the past 12 weeks.
- You do not have diabetes or a history of low blood sugar.
- You have not had weight-loss surgery or used weight-loss medications recently.
- You are not pregnant or breastfeeding, and agree to use birth control during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
This study tests an investigational injection called HRS-4729 to see if it helps people with obesity lose weight. It may offer a new treatment option for those who have been trying to manage their weight with diet and exercise.
This study tests a new injection called SYH2082 in healthy volunteers to see how the body handles it and what side effects might occur. It is an early-stage trial that may help in developing a treatment for weight-related conditions.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This study tests an investigational injection called SYH2069 that may help lower blood sugar in people with type 2 diabetes who are already on metformin. It aims to see if the injection is safe and effective when added to diet, exercise, and metformin.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.